000 | 01040 a2200301 4500 | ||
---|---|---|---|
005 | 20250515144938.0 | ||
264 | 0 | _c20081118 | |
008 | 200811s 0 0 eng d | ||
022 | _a1592-8721 | ||
024 | 7 |
_a10.3324/haematol.13750 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTarghetta, C | |
245 | 0 | 0 |
_aRisk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma. _h[electronic resource] |
260 |
_bHaematologica _cNov 2008 |
||
300 |
_ae66 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aCabras, M G | |
700 | 1 | _aAngelucci, E | |
773 | 0 |
_tHaematologica _gvol. 93 _gno. 11 _gp. e66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.13750 _zAvailable from publisher's website |
999 |
_c18439931 _d18439931 |